Dermatology Advisor19h
Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment
Remibrutinib results in significant improvement in patients still symptomatic after second-generation H1-antihistamine treatment.
2 Minute Medicine5d
Remibrutinib alleviates symptoms in chronic spontaneous urticaria resistant to H1-antihistamines
In this randomized controlled trial, among patients with chronic spontaneous urticaria who continue to have symptoms while on ...
Rolling Out3d
Mast cell activation may be causing your health problems
Discover 8 ways mast cell activation syndrome causes widespread symptoms from digestive issues to brain fog, often mistaken ...
Daily Jang6d
Remibrutinib proves effective against chronic spontaneous urticaria, study
A new groundbreaking study revealed that Remibrutinib showed promising results in treating chronic spontaneous urticaria.A recent study published in the New England Journal of Medicine outlined the ...
Rheumatology Advisor5d
FDA Drug Approval Decisions Expected in April 2025
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.
Ivarmacitinib 4 mg, 8 mg efficacious for adults with severe alopecia areata
For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable, according to a study presented at the ...
Applied Clinical Trials Online4d
Phase III Trial Finds Baricitinib Boosts Hair Regrowth in Adolescents With Severe Alopecia Areata
The BRAVE-AA-PEDS trial found that once-daily baricitinib significantly improved hair regrowth on the scalp, eyebrows, and ...